Medella Therapeutics Ltd.
Sheffield
About Medella Therapeutics Ltd.
Medella Therapeutics, a spinout company from the University of Sheffield, is developing new cancer treatments using monoclonal antibodies – proteins made by the immune system that bind to a single target, such as a cancer cell – that have fewer side effects than many other therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $633.7K
- Funding stage: Seed
- Last round: Seed (Jun 2007)
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/medella-therapeutics-ltd-3341098 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.